Humacyte, Inc. (HUMA) Tops Q4 EPS by 9c
Tweet
Share
E-mailGet Alerts HUMA Hot Sheet
Join SI Premium – FREE
Humacyte, Inc. (NASDAQ: HUMA) reported Q4 EPS of ($0.16), $0.09 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sanuwave Q2 2026 revenue tops revised guidance range
- RBC Capital Downgrades Woolworths Group Ltd (WOW:AU) to Underperform
- JPMorgan Starts Hyundai Department Store (069960:KS) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
